Form 8-K - Current report:
SEC Accession No. 0001213900-22-029854
Filing Date
2022-05-27
Accepted
2022-05-26 20:45:54
Documents
17
Period of Report
2022-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160693-8k_180life.htm   iXBRL 8-K 37052
2 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT DATED MAY 26, 2022 AND EFFECTIVE AS OF ea160693ex10-1_180life.htm EX-10.1 14653
3 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT DATED MAY 26, 2022 AND EFFECTIVE AS OF ea160693ex10-2_180life.htm EX-10.2 14377
4 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT DATED MAY 26, 2022 AND EFFECTIVE AS OF ea160693ex10-3_180life.htm EX-10.3 12835
5 SECOND AMENDMENT TO CONSULTING AGREEMENT DATED MAY 26, 2022 AND EFFECTIVE AS OF ea160693ex10-4_180life.htm EX-10.4 13452
  Complete submission text file 0001213900-22-029854.txt   330206

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atnf-20220526.xsd EX-101.SCH 3798
7 XBRL DEFINITION FILE atnf-20220526_def.xml EX-101.DEF 26891
8 XBRL LABEL FILE atnf-20220526_lab.xml EX-101.LAB 36935
9 XBRL PRESENTATION FILE atnf-20220526_pre.xml EX-101.PRE 25513
11 EXTRACTED XBRL INSTANCE DOCUMENT ea160693-8k_180life_htm.xml XML 5693
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 22972261
SIC: 2834 Pharmaceutical Preparations